Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 319634, 11 pages
http://dx.doi.org/10.1155/2014/319634
Research Article

Analysing Psychosocial Difficulties in Depression: A Content Comparison between Systematic Literature Review and Patient Perspective

1Instituto de Salud Carlos III, Centro Investigación Biométrica en Red (CIBER), C/Diego de León 62, 28006 Madrid, Spain
2Departamento de Psiquiatría, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain
3Instituto de Investigación de la Princesa (IIS-IP), Hospital Universitario de la Princesa, C/Diego de León 62, 28006 Madrid, Spain

Received 4 February 2014; Revised 6 May 2014; Accepted 27 May 2014; Published 9 June 2014

Academic Editor: François Beck

Copyright © 2014 Kaloyan Kamenov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Cuijpers and R. A. Schoevers, “Increased mortality in depressive disorders: a review,” Current Psychiatry Reports, vol. 6, no. 6, pp. 430–437, 2004. View at Google Scholar · View at Scopus
  2. World Health Organization, “World suicide prevention day,” 2012, http://www.who.int/mental_health/prevention/en/.
  3. P. Sobocki, B. Jönsson, J. Angst, and C. Rehnberg, “Cost of depression in Europe,” Journal of Mental Health Policy and Economics, vol. 9, no. 2, pp. 87–98, 2006. View at Google Scholar · View at Scopus
  4. T. B. Üstün, J. L. Ayuso-Mateos, S. Chatterji, C. Mathers, and C. J. L. Murray, “Global burden of depressive disorders in the year 2000,” British Journal of Psychiatry, vol. 184, pp. 386–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. B. Wella, A. Stewart, R. D. Hays et al., “The functioning and well-being of depressed patients. Results from the medical outcomes study,” Journal of the American Medical Association, vol. 262, no. 7, pp. 914–919, 1989. View at Google Scholar · View at Scopus
  6. NCCMH, Depression: The Treatment and Management of Depression in Adults, NICE Clinical Guidelines, No. 90, British Psychological Society, National Institute for Health and Clinical Excellence: Guidance, Leicester, UK, 2010, http://www.ncbi.nlm.nih.gov/books/NBK63748/.
  7. M. Cabello, B. Mellor-Marsá, C. Sabariego, A. Cieza, J. Bickenbach, and J. L. Ayuso-Mateos, “Psychosocial features of depression: a systematic literature review,” Journal of Affective Disorders, vol. 141, no. 1, pp. 22–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Świtaj, M. Anczewska, A. Chrostek et al., “Disability and schizophrenia: a systematic review of experienced psychosocial difficulties,” BMC Psychiatry, vol. 12, article 193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Quintas, A. Raggi, A. M. Giovannetti et al., “Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010,” Epilepsy and Behavior, vol. 25, no. 1, pp. 60–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, International Classification of Functioning, Disability and Health (ICF), World Health Organization, Geneva, Switzerland, 2001.
  11. A. Cieza, S. Chatterji, C. Andersen et al., “ICF Core Sets for depression,” Journal of Rehabilitation Medicine, vol. 36, no. 44, pp. 128–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. K. E. Lasch, M. Hassan, J. Endicott et al., “Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder,” BMC Psychiatry, vol. 12, article 34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. L. Brütt, H. Schulz, and S. Andreas, “Development of an ICF-based core set of activities and participation for patients with mental disorders: an approach based upon data,” Clinical Rehabilitation, vol. 27, no. 8, pp. 758–767, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 3rd edition, 1987.
  15. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 4th edition, 1994.
  16. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 4th edition, 2000.
  17. World Health Organization, International Classification of Diseases and Related Health Problems, Revision (ICD-10), World Health Organization, Geneva, Switzerland, 10th edition, 1992.
  18. O. Sangha, G. Stucki, M. H. Liang, A. H. Fossel, and J. N. Katz, “The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research,” Arthritis Care and Research, vol. 49, no. 2, pp. 156–163, 2003. View at Google Scholar · View at Scopus
  19. E. Frank, R. F. Prien, R. B. Jarrett et al., “Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence,” Archives of General Psychiatry, vol. 48, no. 9, pp. 851–855, 1991. View at Google Scholar · View at Scopus
  20. J. L. Fleiss and J. Cohen, “The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability,” Educational and Psychological Measurement, vol. 33, no. 3, pp. 613–619, 1973. View at Google Scholar
  21. R. A. Krueger and M. A. Casey, Focus Groups: A Practical Guide for Applied Research, Sage, 4th edition, 2009.
  22. D. L. Morgan, “Focus groups,” Annual Review of Sociology, vol. 22, pp. 129–152, 1996. View at Google Scholar · View at Scopus
  23. A. Cieza, S. Geyh, S. Chatterji, N. Kostanjsek, B. Üstün, and G. Stucki, “ICF linking rules: an update based on lessons learned,” Journal of Rehabilitation Medicine, vol. 37, no. 4, pp. 212–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Skärsäter, A. Langius, H. Ågren, L. Häggström, and K. Dencker, “Sense of coherence and social support in relation to recovery in first-episode patients with major depression: a one-year prospective study,” International Journal of Mental Health Nursing, vol. 14, no. 4, pp. 258–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Choenarom, R. A. Williams, and B. M. Hagerty, “The role of sense of belonging and social support on stress and depression in individuals with depression,” Archives of Psychiatric Nursing, vol. 19, no. 1, pp. 18–29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Jaeger, S. Berns, S. Uzelac, and S. Davis-Conway, “Neurocognitive deficits and disability in major depressive disorder,” Psychiatry Research, vol. 145, no. 1, pp. 39–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. N. Seidman and S. P. Roose, “The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial,” Journal of Sex and Marital Therapy, vol. 32, no. 3, pp. 267–273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Y. Dombrovski, E. J. Lenze, M. A. Dew et al., “Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy,” Journal of the American Geriatrics Society, vol. 55, no. 9, pp. 1325–1332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. ten Doesschate, M. W. J. Koeter, C. L. H. Bockting, and A. H. Schene, “Health related quality of life in recurrent depression: a comparison with a general population sample,” Journal of Affective Disorders, vol. 120, no. 1–3, pp. 126–132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Cui, J. M. Lyness, X. Tu, D. A. King, and E. D. Caine, “Does depression precede or follow executive dysfunction? Outcomes in older primary care patients,” The American Journal of Psychiatry, vol. 164, no. 8, pp. 1221–1228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Brunnauer, G. Laux, I. David, M. Fric, I. Hermisson, and H.-J. Möller, “The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients,” Journal of Clinical Psychiatry, vol. 69, no. 12, pp. 1880–1886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Skärsäter, A. Baigi, and L. Haglund, “Functional status and quality of life in patients with first-episode major depression,” Journal of Psychiatric and Mental Health Nursing, vol. 13, no. 2, pp. 205–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Gilmour and S. B. Patten, “Depression and work impairment,” Health Reports/Statistics Canada, Canadian Centre for Health Information, vol. 18, no. 1, pp. 9–22, 2007. View at Google Scholar · View at Scopus
  34. U. Leskelä, T. Melartin, H. Rytsälä, P. Sokero, P. Lestelä-Mielonen, and E. Isometsä, “The influence of major depressive disorder on objective and subjective social support: a prospective study,” Journal of Nervous and Mental Disease, vol. 196, no. 12, pp. 876–883, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Fujiwara and I. Kawachi, “A prospective study of individual-level social capital and major depression in the United States,” Journal of Epidemiology and Community Health, vol. 62, no. 7, pp. 627–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. V. G. Vitriol, S. T. Ballesteros, R. U. Florenzano, K. P. Weil, and D. F. Benadof, “Evaluation of an outpatient intervention for women with severe depression and a history of childhood trauma,” Psychiatric Services, vol. 60, no. 7, pp. 936–942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. C. Markowitz, A. E. Skodol, E. Petkova et al., “Longitudinal effects of personality disorders on psychosocial functioning of patients with major depressive disorder,” Journal of Clinical Psychiatry, vol. 68, no. 2, pp. 186–193, 2007. View at Google Scholar · View at Scopus
  38. I. Skärsäter, “Parents with first time major depression: perceptions of social support for themselves and their children,” Scandinavian Journal of Caring Sciences, vol. 20, no. 3, pp. 308–314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Sir, R. F. D'Souza, S. Uguz et al., “Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms,” Journal of Clinical Psychiatry, vol. 66, no. 10, pp. 1312–1320, 2005. View at Google Scholar · View at Scopus
  40. O. Caliyurt and F. Guducu, “Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder,” Journal of Affective Disorders, vol. 88, no. 1, pp. 75–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. J. F. Karp, D. Weiner, K. Seligman et al., “Body pain and treatment response in late-life depression,” The American Journal of Geriatric Psychiatry, vol. 13, no. 3, pp. 188–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. H. Rapaport, R. B. Lydiard, C. D. Pitts et al., “Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial,” Journal of Clinical Psychiatry, vol. 70, no. 1, pp. 46–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. G. I. Keitner, S. J. Garlow, C. E. Ryan et al., “A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression,” Journal of Psychiatric Research, vol. 43, no. 3, pp. 205–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Saghafi, C. Brown, M. A. Butters et al., “Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder,” International Journal of Geriatric Psychiatry, vol. 22, no. 11, pp. 1141–1146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Lee, L. Shu, X. Xu et al., “Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil,” Psychiatry and Clinical Neurosciences, vol. 61, no. 3, pp. 295–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Sokero, T. Melartin, H. Rytsälä, U. Leskelä, P. Lestelä-Mielonen, and E. Isometsä, “Adequacy of, attitudes toward, and adherence to treatments by suicidal and nonsuicidal depressed patients,” Journal of Nervous and Mental Disease, vol. 196, no. 3, pp. 223–229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. T. T. Brockow, K. Wohlfahrt, A. Hillert et al., “Identifying the concepts contained in outcome measures of clinical trials on depressive disorders using the International Classification of Functioning, Disability and Health as a reference,” Journal of Rehabilitation Medicine, vol. 36, no. 44, pp. 49–55, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Versiani, R. Moreno, C. J. A. Ramakers-Van Moorsel, and A. J. Schutte, “Comparison of the effects of mirtazapine and flouxetine in severely depressed patients,” CNS Drugs, vol. 19, no. 2, pp. 137–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Mann, S. Gilbody, and D. Richards, “Putting the “Q” in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures,” Social Psychiatry and Psychiatric Epidemiology, vol. 44, no. 7, pp. 569–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Nickel, C. Lahmann, K. Tritt et al., “Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study,” Journal of Affective Disorders, vol. 87, no. 2-3, pp. 243–252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. M. H. Trivedi, “The link between depression and physical symptoms,” The Primary Care Companion to the Journal of Clinical Psychiatry, vol. 6, pp. 12–16, 2004. View at Google Scholar
  52. G. E. Simon, M. VonKorff, M. Piccinelli, C. Fullerton, and J. Ormel, “An international study of the relation between somatic symptoms and depression,” The New England Journal of Medicine, vol. 341, no. 18, pp. 1329–1335, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. J. B. W. Williams, “Standardizing the Hamilton Depression Rating Scale: past, present, and future,” European Archives of Psychiatry and Clinical Neuroscience, vol. 251, no. 2, pp. 6–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. J. E. Ware Jr. and B. Gandek, “Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project,” Journal of Clinical Epidemiology, vol. 51, no. 11, pp. 903–912, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Power, A. Harper, and M. Bullinger, “The World Health Organization WHOQOL-100: tests of the universality of quality of life in 15 different cultural groups worldwide,” Health Psychology, vol. 18, no. 5, pp. 495–505, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. M. C. Wichers, D. Q. C. M. Barge-Schaapveld, N. A. Nicolson et al., “Reduced stress-sensitivity or increased reward experience: the psychological mechanism of response to antidepressant medication,” Neuropsychopharmacology, vol. 34, no. 4, pp. 923–931, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Wichers, F. Peeters, N. Geschwind et al., “Unveiling patterns of affective responses in daily life may improve outcome prediction in depression: a momentary assessment study,” Journal of Affective Disorders, vol. 124, no. 1-2, pp. 191–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Geschwind, N. A. Nicolson, F. Peeters, J. van Os, D. Barge-Schaapveld, and M. Wichers, “Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy,” European Neuropsychopharmacology, vol. 21, no. 3, pp. 241–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. P. S. Wang, A. L. Beck, P. Berglund et al., “Effects of major depression on moment-in-time work performance,” The American Journal of Psychiatry, vol. 161, no. 10, pp. 1885–1891, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Peeters, N. A. Nicolson, J. Berkhof, P. Delespaul, and M. De Vries, “Effects of daily events on mood states in major depressive disorder,” Journal of Abnormal Psychology, vol. 112, no. 2, pp. 203–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. J. S. Silk, L. Steinberg, and A. S. Morris, “Adolescents' emotion regulation in daily life: links to depressive symptoms and problem behavior,” Child Development, vol. 74, no. 6, pp. 1869–1880, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Wichers, C. J. P. Simons, I. M. A. Kramer et al., “Momentary assessment technology as a tool to help patients with depression help themselves,” Acta Psychiatrica Scandinavica, vol. 124, no. 4, pp. 262–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. K. E. Heron and J. M. Smyth, “Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments,” British Journal of Health Psychology, vol. 15, no. 1, pp. 1–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Kramer, C. J. Simons, J. A. Hartmann et al. et al., “A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial,” World Psychiatry, vol. 13, pp. 68–77, 2014. View at Google Scholar